Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV
· Real-Time Price · USD
11.84
0.09 (0.77%)
At close: Aug 15, 2025, 3:59 PM
11.85
0.08%
After-hours: Aug 15, 2025, 05:36 PM EDT
Roivant Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Net Income | -356.73M | -286.86M | 4.76B | 4.62B | 4.23B | 4.35B | -1.07B | -740.72M | -412.88M | -352.01M |
Depreciation & Amortization | -37.21M | -33.41M | 20.34M | 21.08M | 22.04M | 22.76M | 24.34M | 18.76M | 12.92M | 6.97M |
Stock-Based Compensation | 289.03M | 252.26M | 151.24M | 200.56M | 199.63M | 178.18M | 123.86M | 74.54M | 25.28M | n/a |
Other Working Capital | 34.65M | -4.93M | -15.76M | 65K | -3.65M | 32.08M | -1.92M | -20.84M | 26.34M | -4.46M |
Other Non-Cash Items | -766M | -720.27M | -5.69B | -5.53B | -5.24B | -5.41B | 69.79M | 7.13M | -50.92M | 119.71M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -77.05M | -95.58M | -21.27M | -14.46M | 19.04M | 24.26M | 5.81M | -11.32M | 23.92M | 2.74M |
Operating Cash Flow | -839.45M | -775.34M | -778.54M | -708.16M | -765.27M | -835.9M | -848.04M | -651.61M | -401.68M | -222.59M |
Capital Expenditures | -4.6M | -4.14M | -2.67M | -1.94M | -1.38M | -2.65M | -2.81M | -2.53M | -2.13M | -508K |
Cash Acquisitions | 74.93M | -804K | 109.58M | -804K | -804K | 114.56M | 111.47M | 111.47M | 111.47M | -3.09M |
Purchase of Investments | -4.06B | -4.06B | -3.4B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 1.96B | 960M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -3.03B | -3.02B | 1.95B | 5.21B | 5.21B | 5.2B | -34.97M | 1.21M | 702K | 88K |
Investing Cash Flow | -1.77B | -2.83B | 1.95B | 5.2B | 5.2B | 5.31B | 73.7M | 110.15M | 110.04M | -3.51M |
Debt Repayment | 5.84M | -60.41M | -18.89M | -24.87M | -30.85M | -31.22M | -31.07M | -23.27M | -15.46M | -7.42M |
Common Stock Repurchased | -1.29B | -997.79M | -754.44M | -648.38M | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -9.1M | 3.93M | -38.85M | -14.54M | 13.42M | 8.97M | 31.15M | 15.29M | 9K | -1.11M |
Financial Cash Flow | -1.22B | -1.08B | -565.67M | -248.73M | 419.36M | 662.32M | 580.18M | 372.3M | 364.83M | 154.5M |
Net Cash Flow | -3.77B | -4.62B | 605.68M | 4.24B | 4.86B | 5.14B | -117.85M | -91.39M | 151.08M | n/a |
Free Cash Flow | -844.05M | -779.48M | -781.21M | -710.11M | -766.65M | -838.55M | -850.85M | -654.15M | -403.81M | -223.1M |